From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Psychiatry>
  4. Summary and Comment

Don't Forget to Use Them After Stroke

An antidepressant improves memory in nondepressed poststroke patients.

Poststroke depression is common and responds to and can even be prevented by antidepressants, which can also improve motor and cognitive outcomes and activities of daily living. These researchers analyzed the effects of escitalopram on cognitive functioning in 129 stroke patients who had participated in a larger, 1-year study on the prevention of poststroke depression. Participants (age range, 50–90 years) were excluded if they had depression, a comprehension deficit, or impaired decision making. They were randomized within 3 months of stroke to receive escitalopram (10 mg), placebo, or problem-solving therapy.

After adjustment for covariates, including baseline scores and age, the escitalopram group showed significantly greater improvement at 1 year than the combined therapy–placebo group on tests of overall cognition, immediate memory, and delayed memory. Overall function and functional memory also improved more with escitalopram. No changes were seen in attention, language, visual-spatial/constructional, or executive functions.

Comment: SSRIs may have multiple neurophysiological effects, including hippocampal neurogenesis and neuroplasticity. Whether these effects are critical for antidepressant efficacy is unclear, but they might be responsible for the cognitive improvement demonstrated here. Apparently, the authors did not control for the effects on immediate memory when they analyzed changes in overall function and delayed memory. Since delayed memory is dependent on immediate memory (if you don't recall it right away, you won't remember it after 15 minutes), the overall results may be explained by the improvement in immediate memory.

Other studies suggest that noradrenergic drugs (amphetamines) and acetylcholinesterase inhibitors also improve poststroke recovery and cognition. A single study is needed to compare the nature and extent of improvement with each drug type. Considering the safety of SSRIs, they should be considered for treatment of all poststroke patients. In addition, their effect on recovery from other disorders, such as traumatic brain injury, should be explored.

Jonathan Silver, MD

Published in Journal Watch Psychiatry February 22, 2010

Citation(s):

Jorge RE et al. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010 Feb; 67:187.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2010. Massachusetts Medical Society. All rights reserved.